Demographic patterns and disparities in new HIV diagnoses attributed to injection drug use in the United States

Joseph G Rosen; Javier Cepeda; Ju Nyeong Park

doi:10.1097/QAD.0000000000003688

Demographic patterns and disparities in new HIV diagnoses attributed to injection drug use in the United States

AIDS. 2023 Nov 15;37(14):2262-2265. doi: 10.1097/QAD.0000000000003688. Epub 2023 Oct 26.

Authors

Joseph G Rosen¹, Javier Cepeda², Ju Nyeong Park^{3

4

5}

Affiliations

¹ Department of International Health.
² Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.
³ Harm Reduction Innovation Lab, Rhode Island Hospital.
⁴ Department of Epidemiology, School of Public Health.
⁵ Department of General Internal Medicine, Warren Alpert Medical School, Brown University, Providence, RI, USA.

Abstract

People who inject drugs (PWID) exhibit disproportionate HIV burdens in the United States. We characterized longitudinal patterns and demographic disparities in new HIV diagnoses attributed to injection drug use (IDU) in 2008-2020. Although new IDU-attributed HIV diagnoses fell by 53.9%, new HIV diagnoses remained disproportionately elevated in female (100.9/100 000), Black (258.8/100 000), and Hispanic (131.0/100 000) PWID. Despite considerable declines in new HIV diagnoses, disparities by race/ethnicity and sex persist among US PWID.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Black or African American
Ethnicity
Female
HIV Infections* / diagnosis
HIV Infections* / epidemiology
Hispanic or Latino
Humans
Substance Abuse, Intravenous* / complications
Substance Abuse, Intravenous* / epidemiology
United States / epidemiology

Abstract

Publication types

MeSH terms

Grants and funding